Shriram K Sundararaman

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

High Throughput Sequencing

Top Venues

Cancer research

Cancer discovery

Dana Farber Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana Farber Cancer Institute

United States

Graduate Student :: Medical Oncology

Publications

Ryohei Yoshida, Maria Saigí, Tetsuo Tani, Benjamin F Springer, Hirofumi Shibata, Shunsuke Kitajima, Navin R Mahadevan, Marco Campisi, Jong Wook Kim, Yoshihisa Kobayashi, Tran C Thai, Koji Haratani, Yurie Yamamoto, Shriram K Sundararaman, Erik H Knelson, Amir Vajdi, Israel Cañadas, Ravindra Uppaluri, Cloud P Paweletz, Juan J Miret, Patrick H Lizotte, Prafulla C Gokhale, Pasi A Janne, David A Barbie
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer. Cancer research 82 (21) (2022)
Thomas L Olson, HeeJin Cheon, Jeffrey C Xing, Kristine C Olson, Umadevi Paila, Cait E Hamele, Yaseswini Neelamraju, Bryna C Shemo, Matt Schmachtenberg, Shriram K Sundararaman, Mariella F Toro, Cheryl A Keller, Emily A Farber, Suna Onengut-Gumuscu, Francine E Garrett-Bakelman, Ross Cameron Hardison, Thomas P Loughran, Aakrosh Ratan, Thomas P Loughran
Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias. Blood 138 (8) (2021)
Shunsuke Kitajima, Elena Ivanova, Sujuan Guo, Ryohei Yoshida, Marco Campisi, Shriram K Sundararaman, Shoichiro Tange, Yoichiro Mitsuishi, Tran C Thai, Sayuri Masuda, Brandon P Piel, Lynette M Sholl, Paul T Kirschmeier, Cloud P Paweletz, Hideo Watanabe, Mamiko Yajima, David A Barbie
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer. Cancer discovery 9 (1) (2018)